United States · FDA National Drug Code directory
RYTARY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64896-661_ef3fe5ab-c753-409b-a5f3-b55e3eefd070
- Product NDC
- 64896-661
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- Amneal Pharmaceuticals LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150112
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVODOPA — 95 mg/1
- CARBIDOPA HYDRATE — 23.75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-01) · 64896-661-01
- 25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-09) · 64896-661-09
- 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-43) · 64896-661-43
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-99) · 64896-661-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →